Legal & Regulatory

Latest News

February 22nd 2009

A REMS Will Be Part of the Expected Launch of Anti-Epilepsy Drug From Ovation Pharmaceuticals

FDA specifies a patient registry and follow-up studies

Trending on Pharmaceutical Commerce

CVS Health’s Breakup: A Turning Point for Pharma Supply Chains or a Redistribution of Market Power?

The End of the Traditional Launch: How JCA, HTA Evolution and Pricing Pressures Are Driving Continuous Evidence Generation

When Drug Pricing Collides With Politics

Idle US Capacity Could Anchor Generic Drug Reshoring, APIIC Says

Executive Conversations: Why Trade Strategy Has to Start Before Launch